Allworth Financial LP boosted its stake in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 1,448.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,719 shares of the company’s stock after buying an additional 8,156 shares during the period. Allworth Financial LP’s holdings in Doximity were worth $535,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of the business. Bank of Nova Scotia bought a new stake in shares of Doximity in the 1st quarter worth $651,000. Jump Financial LLC bought a new position in Doximity in the 1st quarter worth about $3,125,000. Hsbc Holdings PLC increased its position in shares of Doximity by 752.1% during the 1st quarter. Hsbc Holdings PLC now owns 141,191 shares of the company’s stock valued at $8,120,000 after purchasing an additional 124,622 shares during the last quarter. Strs Ohio purchased a new position in Doximity in the 1st quarter worth approximately $665,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in Doximity during the 1st quarter valued at approximately $801,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.
Insider Activity
In related news, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $66.44, for a total value of $132,880.00. Following the transaction, the director directly owned 19,839 shares of the company’s stock, valued at $1,318,103.16. This trade represents a 9.16% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction on Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the completion of the sale, the director directly owned 3,221 shares of the company’s stock, valued at approximately $241,575. This trade represents a 86.13% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 32,000 shares of company stock worth $2,339,580. Corporate insiders own 31.30% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on DOCS
Doximity Stock Performance
DOCS opened at $49.62 on Friday. Doximity, Inc. has a one year low of $47.66 and a one year high of $85.21. The company has a market cap of $9.34 billion, a P/E ratio of 49.62, a PEG ratio of 4.10 and a beta of 1.36. The business’s 50-day simple moving average is $67.58 and its 200-day simple moving average is $62.50.
Doximity (NASDAQ:DOCS – Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.Doximity’s quarterly revenue was up 23.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.30 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. As a group, analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More
- Five stocks we like better than Doximity
- What is the Nikkei 225 index?
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- Insider Trading – What You Need to Know
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- Investing in the High PE Growth Stocks
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
